Clinical Trials Directory

Trials / Completed

CompletedNCT06092567

Post-operative Sensitivity in Composite Restorations

Post-operative Sensitivity in Composites Using Bulk-fill vs. Oblique Incremental Placement Technique: a Double-blind, Randomized Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
90 (actual)
Sponsor
Pakistan Institute of Medical Sciences · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Participants will be divided into groups. In group A, Composite restoration done using oblique incremental technique. In group B, Bulk-fill technique was used. VAS scoring to evaluate the primary outcome at one day, one week and two weeks.

Detailed description

After the approval from ethical research committee, a written informed consent taken. Participants were briefed about the intervention with its associated merits and demerits. The restorative procedures were accomplished under rubber dam isolation using adequate local anesthesia. The principles of minimally intervention and adhesive dentistry were employed. Participants were allocated into two groups. In group A, restorative interventive was performed using Oblique incremental placement while in group B, Bulk-fill technique was used. Post-operative sensitivity was recorded at one day, one week and two week follow up using a Visual analogue scale.

Conditions

Interventions

TypeNameDescription
PROCEDUREGroup A ( Oblique Incremental Placement Technique)In this interventional group, a Nanohybrid composite resin Nexcomp (Meta Biomed, Korea) was placed using an oblique incremental technique with increments not exceeding 2 mm in thickness.
PROCEDUREGroup B (Bulk-fill Placement technique)In this group, a composite Beautifil-Bulk Restorative (SHOFU dental) was utilized for restorative purposes using a bulk-fill technique with a thickness of 4 mm

Timeline

Start date
2022-12-20
Primary completion
2023-07-24
Completion
2023-07-24
First posted
2023-10-23
Last updated
2023-10-23

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT06092567. Inclusion in this directory is not an endorsement.